ozempic glp 1 Is GLP-1 the Same as Ozempic? How Does Ozempic Help With

A notable publication in the New England Journal of Medicine found that patients taking semaglutide had a higher rate of diabetic retinopathy complications compared to those on a placebo

The evolving story of incretins (gip and glp-1) in metabolic and cardiovascular disease: A pathophysiological update

Kieffer TJ, McIntosh CH, Pederson RA

In January 2026, Novo Nordisk, the makers of Ozempic (semaglutide), released the drug as daily oral pill

10.1016/j.peptides.2006.05.011

Further Reading [1] Eli Lilly and Company, 'Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial', Investor press release, May 2026